ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,225.33
-0.27%
Dow Jones
39,133.71
0.06%
Gold vs US Dollar
2,298.37
-0.96%
Brent Oil
84.345
0.19%
Bitcoin
60,758.03
-1.70%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Korro Bio Inc (KRRO)

  7. Korro Bio Inc (KRRO) News

Korro Bio (KRRO)

Korro Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KRRO
DateTimeSourceHeadlineSymbolCompany
17/06/202421:27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KRROKorro Bio Inc
17/06/202421:22Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KRROKorro Bio Inc
12/06/202422:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRROKorro Bio Inc
12/06/202422:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRROKorro Bio Inc
12/06/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRROKorro Bio Inc
05/06/202400:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRROKorro Bio Inc
30/05/202421:01GlobeNewswire Inc.Korro to Participate in Upcoming June Investor and Scientific ConferencesNASDAQ:KRROKorro Bio Inc
23/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KRROKorro Bio Inc
22/05/202421:37Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KRROKorro Bio Inc
20/05/202419:30GlobeNewswire Inc.Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International ConferenceNASDAQ:KRROKorro Bio Inc
15/05/202401:22Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KRROKorro Bio Inc
14/05/202421:34Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:KRROKorro Bio Inc
14/05/202421:20Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KRROKorro Bio Inc
14/05/202421:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRROKorro Bio Inc
14/05/202421:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KRROKorro Bio Inc
14/05/202421:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRROKorro Bio Inc
14/05/202421:01GlobeNewswire Inc.Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical OfficerNASDAQ:KRROKorro Bio Inc
18/04/202413:30GlobeNewswire Inc.Korro Announces $70 Million Private PlacementNASDAQ:KRROKorro Bio Inc
01/04/202421:01GlobeNewswire Inc.Korro to Participate in Upcoming Investor ConferencesNASDAQ:KRROKorro Bio Inc
26/03/202420:01GlobeNewswire Inc.Korro Reports Full Year 2023 Financial Results and Highlights Recent ProgressNASDAQ:KRROKorro Bio Inc
27/02/202413:00GlobeNewswire Inc.Korro to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:KRROKorro Bio Inc
18/01/202413:00GlobeNewswire Inc.Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing PortfolioNASDAQ:KRROKorro Bio Inc
09/01/202414:02Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KRROKorro Bio Inc
09/01/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRROKorro Bio Inc
04/01/202413:00GlobeNewswire Inc.Korro to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:KRROKorro Bio Inc
26/12/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KRROKorro Bio Inc
22/12/202321:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KRROKorro Bio Inc
20/12/202321:44Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:KRROKorro Bio Inc
07/12/202313:00GlobeNewswire Inc.Korro Announces Selection of its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)NASDAQ:KRROKorro Bio Inc
01/12/202321:07Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:KRROKorro Bio Inc
 Showing the most relevant articles for your search:NASDAQ:KRRO

Your Recent History

LSE
LLOY
Lloyds Banking
LSE
PANR
Pantheon Resources
LSE
QBT
Quantum Blockchain Techn...
LSE
POS
Plexus
LSE
EEE
Empire Metals
LSE
GKP
Gulf Keystone Petroleum
LSE
PHNX
Phoenix
LSE
AAZ
Anglo Asian Mining
LSE
VAST
Vast Resources
LSE
ENET
Ethernity Networks
LSE
THG
Thg
LSE
TERN
Tern
LSE
ALTN
Altyngold
LSE
GMET
Golden Metal Resources
LSE
GDR
Genedrive
LSE
AAU
Ariana Resources
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved